6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18243095 | PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE | SHAMEEM, GOLAM M | 1621 | Non-Final OA | Sep 06, 2023 |
| 18264183 | METHODS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | MOU, LIYUAN | 1628 | Non-Final OA | Aug 03, 2023 |
| 18264187 | METHODS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | HAVLIN, ROBERT H | 1626 | Non-Final OA | Aug 03, 2023 |
| 18256099 | INHIBITORS OF NLRP3 | SEITZ, ANTHONY JOSEPH | 1629 | Final Rejection | Jun 06, 2023 |
| 17917450 | COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | SCHMIDT, IZABELA MARIA | 1621 | Final Rejection | Oct 06, 2022 |
| 17783941 | COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA | ANDERSON, REBECCA L | 1626 | Non-Final OA | Jun 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial